<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-title>Critical Care</journal-title><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">17105656</article-id><article-id pub-id-type="pmc">1794465</article-id><article-id pub-id-type="publisher-id">cc5097</article-id><article-id pub-id-type="doi">10.1186/cc5097</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Severe brain injury ICU outcomes are associated with Cranial-Arterial Pressure Index and noninvasive Bispectral Index and transcranial oxygen saturation: a prospective, preliminary study</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Dunham</surname><given-names>C Michael</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>michael_dunham@hmis.org</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Ransom</surname><given-names>Kenneth J</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>kenneth_ransom@hmis.org</email></contrib><contrib id="A3" contrib-type="author"><name><surname>McAuley</surname><given-names>Clyde E</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>clyde_mcauley@hmis.org</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Gruber</surname><given-names>Brian S</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>brian_gruber@hmis.org</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Mangalat</surname><given-names>Dev</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>devman@dublin.com</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Flowers</surname><given-names>Laurie L</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>laurie_flowers@hmis.org</email></contrib></contrib-group><aff id="I1"><label>1</label>Trauma/Critical Care Services, St Elizabeth Health Center, Youngstown, OH 44501, USA</aff><pub-date pub-type="ppub"><year>2006</year></pub-date><pub-date pub-type="epub"><day>14</day><month>11</month><year>2006</year></pub-date><volume>10</volume><issue>6</issue><fpage>R159</fpage><lpage>R159</lpage><ext-link ext-link-type="uri" xlink:href="http://ccforum.com/content/10/6/R159"/><history><date date-type="received"><day>4</day><month>8</month><year>2006</year></date><date date-type="rev-request"><day>13</day><month>10</month><year>2006</year></date><date date-type="rev-recd"><day>19</day><month>10</month><year>2006</year></date><date date-type="accepted"><day>14</day><month>11</month><year>2006</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2006 Dunham et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder>Dunham et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Dunham
               C Michael
               
               michael_dunham@hmis.org
            </dc:author><dc:title>
            Severe brain injury ICU outcomes are associated with Cranial-Arterial Pressure Index and noninvasive Bispectral Index and transcranial oxygen saturation: a prospective, preliminary study
         </dc:title><dc:date>2006</dc:date><dcterms:bibliographicCitation>Critical Care 10(6): R159-. (2006)</dcterms:bibliographicCitation><dc:identifier type="sici">1364-8535(2006)10:6&#x0003c;R159&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1364-8535</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Introduction</title><p>The purpose of this study was to determine if noninvasive transcranial oxygen saturation (StcO<sub>2</sub>) and Bispectral Index (BIS) correlate with severe traumatic brain injury intensive care unit (ICU) outcomes.</p></sec><sec sec-type="methods"><title>Methods</title><p>This is a prospective observational study. Values of intracranial pressure (ICP), mean arterial pressure (MAP), BIS, and StcO<sub>2 </sub>were recorded hourly for the first six, post-injury days in 18 patients with severe brain injury. Included in the analyses was the Cranial-Arterial Pressure (CAP) Index, which is ICP/(MAP - ICP).</p></sec><sec><title>Results</title><p>After 1,883 hours of data were analyzed, we found that StcO<sub>2 </sub>and BIS are associated with survival, good neurological outcome, ICP &#x02264;20, cerebral perfusion pressure (CPP) &#x02265;60, and CAP index &#x02264;0.30 (<italic>p </italic>&#x02264; 0.001). Survival and good outcome are independently associated with BIS &#x02265;60, StcO<sub>2 </sub>&#x02265;70, and ICP &#x02264;20 (<italic>p </italic>&#x0003c; 0.0001). BIS &#x02265;60 or StcO<sub>2 </sub>&#x02265;70 is associated with survival, good outcome, CPP &#x02265;60, ICP &#x02264;20, CAP index &#x02264;0.30, and fewer ICP interventions (<italic>p </italic>&#x0003c; 0.0001). With BIS &#x02265;60 or StcO<sub>2 </sub>&#x02265;70, the rate of CPP &#x02265;60 is 97.2% and the rate of ICP&#x02264; 25 is 97.1%. An increased CAP index is associated with death, poor neurological outcome, and increased ICP interventions (<italic>p </italic>&#x0003c; 0.0001). With CAP index &#x0003e;0.25, MAP is not related to ICP (<italic>p </italic>= 0.16).</p></sec><sec><title>Conclusion</title><p>Numerous significant associations with ICU outcomes indicate that BIS and StcO<sub>2 </sub>are clinically relevant. The independent associations of BIS, StcO<sub>2</sub>, and ICP with outcomes suggest that noninvasive multi-modal monitoring may be beneficial. Future studies of patients with BIS &#x02265;60 or StcO<sub>2 </sub>&#x02265;70 will determine if select patients can be managed without ICP monitoring and whether marginal ICP can be observed. An increased CAP index is associated with poor outcome.</p></sec></abstract></article-meta></front><body><sec><title>Introduction</title><p>The primary clinical objective after severe brain trauma is to prevent secondary injury, a common sequel to the primary, mechanical impact. The concept is to prevent cerebral hypoxia by maintaining sufficient oxygen delivery to meet the oxidative metabolic needs of the intracranial neural tissues. This implies that cerebral blood flow, arterial oxygen saturation, and hemoglobin concentration in a specific patient need to be adequate.</p><p>Intracranial pressure (ICP) and cerebral perfusion pressure (CPP) (mean arterial pressure (MAP) - ICP) monitoring is recommended for severe brain injury. There are several limitations of ICP and CPP monitoring: the ICP device is invasive and insertion requires rigorous training [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]; distinct ICP and CPP target recommendations are uncertain [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]; CPP is not equivalent to cerebral blood flow [<xref ref-type="bibr" rid="B5">5</xref>]; and, additionally, arterial oxygen content (arterial oxygen saturation (SaO<sub>2</sub>) and hemoglobin) and oxidative cerebral tissue needs, relative to oxygen delivery, are not intrinsic components of ICP and CPP.</p><p>Near-infrared oximetry provides a noninvasive method for measuring transcranial oxygen saturation (StcO<sub>2</sub>). StcO<sub>2 </sub>estimates regional cerebral capillary/venous oxygen saturation [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>] StcO<sub>2 </sub>monitoring provides an opportunity to determine whether cerebral cortical oxygen delivery is adequate to meet cellular oxidative needs. Dunham and colleagues have shown that cerebral oximetry values correlate with outcomes and CPP following severe brain injury [<xref ref-type="bibr" rid="B9">9</xref>]. These findings have been corroborated by others [<xref ref-type="bibr" rid="B10">10</xref>].</p><p>A repertoire of electrical activity continuously emanates from the superficial cerebral cortex and can be displayed on an electroencephalogram (EEG). EEG tracings have been shown to be variably altered by sedatives, hypoxia, hypercarbia, ischemia, and intracranial hypertension [<xref ref-type="bibr" rid="B11">11</xref>]. The noninvasive, Bispectral Index (BIS) monitor creates a computer-processed summary of EEG brain wave activity [<xref ref-type="bibr" rid="B12">12</xref>]. The algorithm generates an ordinal number that rates level of hypnosis during anesthesia. Although BIS values have been shown to correlate with some intensive care unit (ICU) conditions, documented experience with severe brain injury is limited.</p><p>CPP monitoring is an attempt to estimate global cerebral blood flow. StcO<sub>2 </sub>monitoring assesses frontal cerebral cortical oxygen extraction (the relationship between oxygen delivery and consumption). BIS values are influenced by frontal cortical electrical activity. The study purpose is to determine the relationships between StcO<sub>2 </sub>and BIS values in severe brain injury and ICU outcomes (survival, discharge Glasgow Coma Scale (GCS) score, ICP, CPP, and interventions to lower ICP).</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Patient characteristics</title><p>Patients were considered for study entry if they had blunt traumatic head injury, initial GCS score &#x02264; 8, brain computed tomography (CT) scan that demonstrated a hemorrhagic lesion, age between 18 and 65 years, and an ICP monitor inserted within 24 hours post-injury. A CT hemorrhagic lesion (intracranial hemorrhage) was defined as the presence of an epidural hematoma, subdural hematoma, cerebral contusion, cerebral hemorrhage, or subarachnoid hemorrhage. Patients were excluded if there was pre-hospital cardiac arrest, near-brain-death clinical findings after resuscitation, pre-existing medical coagulopathy, or a body mass index &#x02265; 35 kg/m<sup>2</sup>. The Institutional Review Board for human investigations approved the study.</p></sec><sec><title>Patient monitoring</title><p>BIS and StcO<sub>2 </sub>monitoring began when the ICP device was inserted and study consent was obtained. Each hour, ICP, MAP, StcO<sub>2</sub>, and BIS were monitored and recorded by the nursing staff. Cerebrospinal fluid (CSF) aspiration and mannitol administration were recorded hourly.</p><p>StcO<sub>2 </sub>was measured with the INVOS 4100 system (Somanetics Corporation, Troy, MI, USA). Self-adhesive skin patches, which contain a near-infrared light-emitting diode and two photodiode detectors to measure returning scattered light intensities, were applied to the patient's left and right forehead. The skin patches were connected to cables that communicate with a computer and a near-infrared light generator. Harmless near-infrared light is generated by the light-emitting diode. Photons easily pass through scalp and bone tissue and enter the cerebral cortex. Photons are scattered back to the two detectors. The detector near the emitting-diode measures photons in the superficial tissues (scalp and bone), whereas the far detector includes photons from the deep tissues (scalp, bone, and cerebral cortex). Hemoglobin molecules within capillary red blood cells are measured by each detector at the wavelengths of 730 (deoxyhemoglobin) and 810 (total hemoglobin) nanometers. The signal difference between the near and far detectors allows a calculation of regional capillary/venous oxygen saturation in the cerebral cortex. The oxygen saturation values reflect the balance between cerebral cortical oxygen delivery and consumption. This information is converted to a digital format and oxy-hemoglobin saturation is derived from these values. The StcO<sub>2 </sub>values are then displayed in real time on the computer screen. The mean value for the left and right sides was computed.</p><p>The noninvasive, A-2000 Bispectral Index XP Monitoring System (Aspect Medical Systems, Inc., Newton, MA, USA) continuously processes raw EEG signals to produce a single number, or BIS. BIS was designed to correlate with hypnotic clinical endpoints (sedation, lack of awareness, and memory) in order to track changes in the effects of anesthetics on the brain. The BIS correlates with the patient's level of hypnosis, where 100 indicates that the patient is awake and 0 represents a flat line EEG. The forehead sensor transmits EEG signals to the digital signal converter. The converter amplifies and digitizes these signals, then sends them to the monitor. The monitor software filters the data, analyzes it for artifacts, and processes it using digital signal processing techniques. The output from a multivariate discriminate analysis quantifies the overall bispectral properties (frequency, power, and phase) throughout the entire frequency range. The self-adhesive skin patch was randomly applied to the patient's left or right forehead. One side was selected whenever the opposite side had soft tissue injury.</p></sec><sec><title>Patient interventions</title><p>Full-time surgical intensivists (four) and neurosurgeons (three) managed all patients and ordered interventions based on hourly ICP and CPP values. The hourly StcO<sub>2 </sub>and BIS values did not influence treatment decisions.</p><p>Routine clinical targets included: isotonic fluid administration at maintenance rates, hemoglobin &#x0003e;10 g/dL, SaO<sub>2 </sub>&#x0003e;92%, arterial carbon dioxide partial pressure (PaCO<sub>2</sub>) 35 to 42 torr, MAP 80 to 90 torr, head of bed elevation (15 to 30 degrees), euthermia, CPP &#x02265;60 torr, euvolemia or mild hypervolemia, cardiac index &#x02265;3.0 L/min/m<sup>2</sup>, serum osmolality &#x02265;290 mOsm/kg, and serum lactate &#x02264;2.5 mmol/L. Primary interventions for patients with ICP &#x0003e;20 torr included: brain CT scan to detect surgical lesions and the need for craniotomy, sedation when MAP &#x02265;85 torr, CSF drainage, neuromuscular blockade for motor hyperactivity uncontrolled by sedatives or sedative-induced hypotension, mannitol (if serum osmolality &#x0003c;320 mOsm/kg or earlier, if cerebral edema was present), diuretics (for hypo-osmolar serum and/or hypervolemia), and modest hyperventilation (PaCO<sub>2 </sub>31 to 34 torr).</p><p>Secondary interventions for recalcitrant intracranial hypertension included: brain CT scan to detect surgical lesions that require a craniotomy, alpha agonist (dopamine (&#x0003e;8 &#x003bc;g/kg/minute), phenylephrine, or norepinephrine) to elevate MAP to a supranormal level, hypothermia, aggressive hyperventilation, barbiturate coma, and decompressive craniectomy. Interventions for systemic arterial hypotension included: for obvious vasodilation (capillary nail bed hyperemia or decreased systemic vascular resistance index), afterload augmentation with an alpha agonist and discontinuance of sedatives; for obvious hypovolemia (low central venous pressure or pulmonary artery occlusion pressure, low cardiac index, or fluid input much less than fluid output), fluid-bolus administration (250 mL of normal saline over 20 minutes), pitressin for diabetes insipidus, or red blood cells for hemoglobin &#x0003c;10 gm/dL; and, for impaired cardiac contractility (cardiac index &#x0003c;3.5 L/min/m<sup>2</sup>, or increased lactate and pulmonary artery occlusion pressure &#x0003e;15 torr), inotropic support. When the etiology was unclear, combinations of the above recommendations were used.</p></sec><sec><title>Data collection</title><p>General information included patient age, gender, Injury Severity score, first-24-hour intracranial CT scan results (epidural hematoma, subdural hematoma, cerebral contusion or hematoma, midline shift &#x0003e;3 mm, abnormal mesencephalic cisterns, subarachnoid hemorrhage), brain Abbreviated Injury Scale score, initial GCS score, need for craniotomy, mortality outcome, and hospital discharge GCS score. Patients were determined to have a good neurological outcome if the hospital discharge GCS score was 9 to 15. Poor neurological outcome was assigned when a patient died or had a hospital discharge GCS score of 3 to 8.</p><p>The ICP, MAP, BIS, and StcO<sub>2 </sub>values were recorded hourly for each of the first six post-injury days. If the ICP device was removed prior to the sixth day, data collection was terminated. Day and hour values represented the period of time that had elapsed since the date and time of each patient's injury. Yes or no values were recorded for CSF drainage (&#x02265;5 mL in past one hour) and mannitol administration (given within the previous two hours). An intervention to lower ICP was considered as yes for a given hour if CSF was drained or mannitol was administered.</p></sec><sec><title>Cranial-Arterial Pressure index</title><p>During preliminary data analyses the ICP to CPP ratio (ICP/(MAP - ICP)) was found to be highly discriminate for surviving and non-surviving patients. This relationship, created by the authors, is referred to as the Cranial-Arterial Pressure (CAP) Index and is included in multiple analyses.</p></sec><sec><title>Statistical analysis</title><p>Data entry and preliminary data analyses were conducted using Epi Info version 6.04d (Centers for Disease Control and Prevention, Atlanta, GA, USA). Data were exported from Epi Info into SAS for windows version 8.00 (SAS statistical software, Cary, NC, USA) for statistical analysis. The Shapiro-Wilk Test is used to determine whether the data are normally distributed. Measurements are reported as the mean value &#x000b1; the standard deviation. Group frequencies are compared with the Chi-square test. Comparison of inter-group continuous variables is by <italic>t</italic>-test. Relationship assessment between two continuous variables is by Pearson correlation coefficient. Multivariate logistic regression analysis is used to evaluate the effect of independent continuous or dichotomous variables (for example, CPP &#x02265;60, ICP &#x02264;20, BIS, and StcO<sub>2</sub>) on dichotomous dependent variables (for example, mortality, neurological outcome). Level of statistical significance was set at <italic>p </italic>&#x0003c; 0.05 for all tests.</p></sec></sec><sec><title>Results</title><p>The study includes 18 consecutive patients and was conducted from July 2005 until May 2006. There are 1,883 concurrent, hourly observations of ICP, CPP, BIS and StcO<sub>2 </sub>values. Injury characteristics are displayed in Table <xref ref-type="table" rid="T1">1</xref>. The data are normally distributed (MAP - W = 0.99; ICP - W = 0.89; CPP - W = 0.98; BIS - W = 0.99; StcO<sub>2 </sub>- W = 0.99; <italic>p </italic>&#x0003c; 0.0001 for all variables). Surviving and good neurological outcome patients have increased CPP, StcO<sub>2</sub>, and BIS and decreased ICP and CAP Index (Table <xref ref-type="table" rid="T2">2</xref>). ICP, CPP, BIS and StcO<sub>2 </sub>rates are: ICP &#x02264;20 = 84.9% (1,598); CPP &#x02265;60 = 93.9% (1,768); BIS &#x02265;60 = 30.9% (582); and StcO<sub>2 </sub>&#x02265;70 = 50.4% (949). Survival is independently associated with ICP &#x02264;20, BIS &#x02265;60, and StcO<sub>2 </sub>&#x02265;70 (<italic>p </italic>&#x0003c; 0.0001). Good neurological outcome is independently associated with ICP &#x02264;20, BIS &#x02265;60, and StcO<sub>2 </sub>&#x02265;70 (<italic>p </italic>&#x0003c; 0.0001). Survival is independently associated with CPP &#x02265;60, BIS &#x02265;60, and StcO<sub>2 </sub>&#x02265;70 (<italic>p </italic>&#x0003c; 0.0001). Good neurological outcome is independently associated with CPP &#x02265;60, BIS &#x02265;60, and StcO<sub>2 </sub>&#x02265; 70 (<italic>p </italic>&#x0003c; 0.0001). Interactive variables are either not statistically significant or have no impact on model predictability.</p><p>StcO<sub>2 </sub>and BIS have an inverse association with ICP and CAP Index, and a direct association with CPP (Table <xref ref-type="table" rid="T3">3</xref>). StcO<sub>2 </sub>has a direct association with BIS (Table <xref ref-type="table" rid="T4">4</xref>). Combined BIS and StcO<sub>2 </sub>rates are: BIS &#x02265;60 or StcO<sub>2 </sub>&#x02265;70 = 61.2% (1,152); and BIS &#x0003c;60 and StcO<sub>2 </sub>&#x0003c;70 = 38.8% (731). BIS &#x02265;60 or StcO<sub>2 </sub>&#x02265;70 is associated with survival, good neurological outcome, CPP &#x02265;60, ICP &#x02264;20, CAP Index &#x02264;0.30, and less interventions to lower ICP (Table <xref ref-type="table" rid="T5">5</xref>). The majority of observations for surviving and good neurological outcome patients have BIS &#x02265;60 or StcO<sub>2 </sub>&#x02265;70. The majority of observations for dying and poor neurological outcome patients have BIS &#x0003c;60 and StcO<sub>2 </sub>&#x0003c;70. With BIS &#x02265;60 or StcO<sub>2 </sub>&#x02265;70, the rate for CPP &#x02265;60 is 97.2% (95% confidence interval (CI) 96.1 to 98.0), the rate for ICP &#x02264;20 is 90.8% (95% CI 89.0 to 92.3%), and the rate for ICP &#x02264;25 is 97.1% (95% CI 96.0 to 98.0%).</p><p>An increasing CAP Index indicates a modest reduction in MAP and substantial increase in ICP (Table <xref ref-type="table" rid="T6">6</xref>). As the CAP Index increases, the magnitude of change in this variable is much greater in comparison to the changes in MAP, ICP, and CPP. The CAP Index is increased with death, poor neurological outcome, and need for interventions to lower ICP (Table <xref ref-type="table" rid="T7">7</xref>). The CAP Index has the following correlation coefficients: ICP - r = 0.70, <italic>p </italic>&#x0003c; 0.0001; MAP - r = -0.18, <italic>p </italic>&#x0003c; 0.0001; and CPP - r = -0.55, <italic>p </italic>&#x0003c; 0.0001. Survival is independently associated with CAP Index and CPP (<italic>p </italic>= 0.0001). Good neurological outcome is independently associated with CAP Index (<italic>p </italic>= 0.0001), but not CPP (<italic>p </italic>= 0.29). The need for interventions to lower ICP (mannitol and/or CSF aspiration) is independently associated with CAP Index and ICP (<italic>p </italic>= 0.0001). The need for interventions to lower ICP (mannitol and/or CSF aspiration) is independently associated with CAP Index (<italic>p </italic>= 0.0001), but not CPP (<italic>p </italic>= 0.08). When the CAP Index is &#x0003e;0.25 (<italic>n </italic>= 365; MAP - 91.0 &#x000b1; 12.0; ICP - 27.1 &#x000b1; 9.1; CPP - 64.0 &#x000b1; 14.6), there is no relationship between MAP and ICP (r = 0.07; <italic>p </italic>= 0.16)</p></sec><sec><title>Discussion</title><p>This is a prospective study evaluating 18 consecutive patients with severe brain injury. It includes 1,883 hourly concurrent observations of ICP, CPP, BIS and StcO<sub>2</sub>. The study findings indicate that BIS and StcO<sub>2 </sub>are clinically relevant variables, because they are associated with ICU outcomes (survival, hospital discharge GCS, ICP, CPP, and interventions to lower ICP). Surviving patients and patients with good neurological outcome have higher BIS and StcO<sub>2 </sub>values. BIS and StcO<sub>2 </sub>are inversely related to ICP and CAP Index and directly associated with CPP. BIS and StcO<sub>2 </sub>have a positive relationship. The data suggest that BIS, StcO<sub>2</sub>, ICP, and CPP are related, but distinct indices of outcome.</p><p>ICP and CPP monitoring have substantial limitations. There are insufficient data to support a treatment standard for ICP treatment threshold, a principle that reflects a high degree of clinical certainty [<xref ref-type="bibr" rid="B3">3</xref>]. ICP treatment should be "initiated at an upper threshold of 20 to 25 mmHg", a principle that reflects a moderate degree of clinical certainty [<xref ref-type="bibr" rid="B3">3</xref>]. The moderate degree of clinical certainty, the nebulous recommendation to initiate treatment, and the ICP range indicate that a precise ICP endpoint has not been realized. There are insufficient data to support a treatment standard for a targeted CPP, a principle that reflects a high degree of clinical certainty [<xref ref-type="bibr" rid="B4">4</xref>]. CPP should be maintained at a minimum of 60 mmHg, a principle that reflects a moderate degree of clinical certainty. Further, ICP devices are invasive and insertion requires expertise [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Further indication that ICP and CPP targets are unclear is the controversy between CPP versus ICP management [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B15">15</xref>] Additionally, CPP does not equate to cerebral blood flow [<xref ref-type="bibr" rid="B5">5</xref>]. Finally, arterial oxygen content (SaO<sub>2 </sub>and hemoglobin) and oxidative cerebral tissue needs, relative to oxygen delivery, are not components of ICP and CPP. These ICP and CPP constraints suggest that additional monitoring techniques are needed.</p><p>The multiple associations of BIS and StcO<sub>2 </sub>with survival, neurological outcome, ICP, and CPP suggest that BIS and StcO<sub>2 </sub>are clinically discriminate parameters. Surviving patients have decreased ICP, increased CPP, decreased CAP Index, increased StcO<sub>2</sub>, and increased BIS. Good neurological outcome patients also have decreased ICP, increased CPP, decreased CAP Index, increased StcO<sub>2</sub>, and increased BIS. Variation in StcO<sub>2 </sub>and BIS are associated with changes in ICP and CPP. Such statistical associations support the validity of StcO<sub>2 </sub>and BIS and their potential clinical utility.</p><p>The independent association of BIS, StcO<sub>2</sub>, and ICP with outcomes indicates that BIS, StcO<sub>2</sub>, and ICP data are complementary. BIS, StcO<sub>2</sub>, ICP, and CPP are related, but distinct indices of outcome with severe brain injury. Survival is independently associated with BIS, StcO<sub>2</sub>, ICP, and CPP. Good neurological outcome is also independently associated with BIS, StcO<sub>2</sub>, ICP, and CPP. Other studies indicate that supplemental monitoring in severe brain injury is associated with clinical benefits. Cruz [<xref ref-type="bibr" rid="B16">16</xref>] showed that managing cerebral extraction of oxygen in conjunction with CPP is associated with better neurological outcomes than when CPP treatment alone is used. Other patients with severe brain injury and receiving multi-modal monitoring have improved survival when compared to ICP and CPP monitoring [<xref ref-type="bibr" rid="B17">17</xref>]. The study and literature findings are in support of severe brain injury multi-modal monitoring.</p><p>The study findings indicate that, when ICP increases or CPP decreases, there is cerebral hypoxia and altered brain wave patterns. With increased ICP or decreased CPP, StcO<sub>2 </sub>is reduced. As well, increased ICP or decreased CPP are associated with a reduction in BIS. Increased BIS is associated with increased StcO<sub>2</sub>.</p><p>BIS &#x02265; 60 or StcO<sub>2 </sub>&#x02265; 70 suggest that patients with severe brain injury are stable. A BIS &#x02265;60 or StcO<sub>2 </sub>&#x02265;70 are associated with survival, good neurological outcome, increased CPP, decreased ICP, decreased CAP Index, and decreased interventions to lower ICP. With a BIS &#x02265;60 or StcO<sub>2 </sub>&#x02265;70, ICP and CPP are likely to be acceptable. A BIS &#x02265;60 or StcO<sub>2 </sub>&#x02265;70 indicate there is a high probability of an acceptable CPP (CPP &#x02265;60, 97.2% rate) and ICP (ICP &#x02264;20, 90.8% rate; ICP &#x02264;25, 97.1% rate).</p><p>Our previous investigation included 3,722 hourly observations of StcO<sub>2 </sub>in patients with severe brain injury [<xref ref-type="bibr" rid="B9">9</xref>]. This study also demonstrates that StcO<sub>2 </sub>is associated with survival and CPP in a similar patient cohort. These findings have been validated by other investigators [<xref ref-type="bibr" rid="B10">10</xref>]. In severe brain injury, BIS values correlate with recovery of consciousness [<xref ref-type="bibr" rid="B18">18</xref>], the raw EEG during barbiturate coma [<xref ref-type="bibr" rid="B19">19</xref>], and brain death [<xref ref-type="bibr" rid="B20">20</xref>]. In patients with variable degrees of brain injury, BIS correlates with positive brain CT scan and neurological outcome [<xref ref-type="bibr" rid="B21">21</xref>].</p><p>Future studies may determine if select patients with a BIS &#x02265;60 or StcO<sub>2 </sub>&#x02265;70 can be managed without ICP monitoring. Potential candidates are blunt trauma patients with intracranial hemorrhage, GCS score 6 to 8, no need for emergency craniotomy, differentiated gray-white matter, no significant midline shift, patent basal cisterns, patent sulci, and reactive, symmetric pupils. With a BIS &#x02265;60 or StcO<sub>2 </sub>&#x02265;70, an ICP monitor may not be necessary. With a BIS &#x0003c;60 and StcO<sub>2 </sub>&#x0003c;70 an ICP monitor is indicated. Other patients who may benefit from BIS and StcO<sub>2 </sub>monitoring without ICP monitoring are blunt trauma patients with intracranial hemorrhage, GCS score 9 to 12, and the need for mechanical ventilation and sedation.</p><p>Additional investigations may prove that a marginal ICP in blunt trauma patients with intracranial hemorrhage and GCS score 3 to 8 does not need to be lowered with BIS &#x02265;60 or StcO<sub>2 </sub>&#x02265;70. Specifically, when ICP is 15 to 20 mmHg and BIS &#x02265;60 or StcO<sub>2 </sub>&#x02265;70, interventions to lower ICP may be unnecessary. However, with BIS &#x0003c;60 and StcO<sub>2 </sub>&#x0003c;70, interventions to lower ICP or increase CPP should be considered.</p><p>The CAP Index is a parameter that was identified during this study. However, no other study, to our knowledge, has described such a relationship. CAP Index is a relationship that readily classifies patients according to neurological outcomes. An elevated CAP Index indicates a modest reduction in MAP and substantial increase in ICP. When comparing the surviving and nonsurviving patients, the mean difference is much greater for the CAP Index than it is for ICP, CPP, StcO<sub>2</sub>, and BIS. Similar relative differences are noted when comparing patients with good neurological outcome and bad outcome. An increased CAP Index is associated with death, poor neurological outcome, and increased interventions to lower ICP. CAP Index is correlated with, but not identical to, ICP, MAP, and CPP. CAP Index has an additional association with survival, good neurological outcome, and lack of need for interventions to lower ICP, independent of ICP and CPP. These findings suggest that the CAP Index is a distinct, interactive parameter. When the CAP Index is increased, there is no relationship between MAP and ICP. When there is no relationship between MAP and ICP, increasing MAP typically will not increase ICP [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>] Thus, when the CAP Index is increased and ICP cannot be reduced, increasing MAP may improve CPP. This implication needs to be tested.</p><p>There are several study limitations. A larger group of patients needs to be evaluated to confirm the observations in this study. Severe forehead, soft tissue injury may prohibit BIS or cerebral oximetry sensor application or alter the BIS or StcO<sub>2 </sub>values. Bilateral frontal lobe contusions may alter the StcO<sub>2 </sub>values, thus impeding their clinical interpretation. A frontal subdural hematoma may interfere with BIS or StcO<sub>2 </sub>values. Discharge GCS score status was included, as one of several measures, to assess ICU outcomes. Admission GCS score was 3 to 8 for all patients, indicating severe neurological impairment. A discharge GCS score of 3 to 8 would indicate relatively poor neurological outcome. A discharge GCS score of 9 to 15 would indicate an improvement and a relatively good neurological outcome, when compared to admission. Because of the above, discharge GCS score was dichotomized as a relative indication of ICU outcome. However, quality of life and Glasgow Outcome score assessment at six months may be a more relevant indication of neurological outcome. These outcomes need to be compared with post-injury BIS and StcO<sub>2 </sub>values. The study focuses on severe traumatic brain injury. CT scan evidence of intracranial hemorrhage was a study inclusion requirement, because it suggests a history of mechanical brain trauma. Severe cognitive impairment due to mechanical brain injury can occur without intracranial hemorrhage, although this is relatively uncommon. With post-traumatic severe cognitive impairment, the absence of intracranial hemorrhage suggests that hypoxemia or shock may be the primary pathology. The study does not address patients with hypoxic encephalopathy, medical subarachnoid hemorrhage, and diffuse axonal injury. A larger group of patients needs to be studied to determine the impact of individual brain pathology on outcomes and BIS and StcO<sub>2 </sub>values. Prospective trials need to be performed to assess the hour-to-hour treatment implications of BIS and StcO<sub>2 </sub>values. The CAP Index, to our knowledge, has never been described in the literature. Additional investigations need to be conducted to define its therapeutic implications. Further studies are required to determine if the prognostic implications found in this study can be corroborated.</p></sec><sec><title>Conclusion</title><p>CPP, BIS, and StcO<sub>2 </sub>monitoring are intended to assess global intracranial blood flow, regional cerebral cortical function, and local cortical oxygen extraction, respectively. The associations of BIS and StcO<sub>2 </sub>with ICU outcomes (survival, neurological outcome, ICP, CPP, CAP Index, and interventions to lower ICP) indicate that BIS and StcO<sub>2 </sub>are clinically discriminate parameters. The independent associations of BIS, StcO<sub>2</sub>, and ICP or CPP with outcomes indicate that BIS, StcO<sub>2</sub>, and ICP values are complementary. Apropos, the noninvasiveness of BIS and StcO<sub>2 </sub>is appealing. ICP and CPP monitoring are limited by non-distinct targets and need for expertise with monitor insertion. Study findings indicate that cerebral hypoxia occurs and brain wave patterns are altered when ICP increases, CPP decreases, or CAP Index increases. BIS &#x02265;60 or StcO<sub>2 </sub>&#x02265;70 suggest that patients with severe brain injury are likely to have an acceptable ICP and CPP. Future studies will define the role for BIS and StcO<sub>2 </sub>monitoring with traumatic brain injury. They will determine if select patients with BIS &#x02265;60 or StcO<sub>2 </sub>&#x02265;70 can be managed without ICP monitoring. Such investigations may prove that an ICP of 16 to 25 mmHg does not need to be lowered with BIS &#x02265;60 or StcO<sub>2 </sub>&#x02265;70. An increased CAP Index is a harbinger of poor outcome. Further studies may show that, when the CAP Index is increased and ICP cannot be reduced, raising MAP will enhance CPP.</p></sec><sec><title>Key messages</title><p>&#x02022; Noninvasive BIS and StcO<sub>2 </sub>values are clinically relevant with severe brain injury.</p><p>&#x02022; ICP, BIS, and StcO<sub>2 </sub>values provide complementary information.</p><p>&#x02022; When ICP increases or CPP decreases, there is cerebral hypoxia and altered brain wave patterns.</p><p>&#x02022; Future studies will determine the therapeutic and diagnostic benefit of BIS and StcO<sub>2 </sub>monitoring.</p><p>&#x02022; CAP Index is a discriminate relationship between ICP and MAP that has prognostic and therapeutic implications.</p></sec><sec><title>Abbreviations</title><p>BIS = Bispectral Index; CAP = Cranial-Arterial Pressure; CI = confidence interval; CPP = cerebral perfusion pressure; CSF = cerebrospinal fluid; CT = computed tomography; EEG = electroencephalogram; GCS = Glasgow Coma Scale; ICP = intracranial pressure; ICU = intensive care unit; MAP = mean arterial pressure; StcO<sub>2 </sub>= transcranial oxygen saturation.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>CMD conceived and coordinated the study, and was involved in the study organization, data collection, analysis, and interpretation, and manuscript draft and revisions. KJR was involved in the study organization, data analysis and interpretation, and manuscript draft and revisions. CEM participated in the study organization, data interpretation, and manuscript draft and revisions. BSG contributed to the study organization, data interpretation, and manuscript draft and revisions. DM was involved in the data collection, analysis, and interpretation, and manuscript revisions. LF contributed to the study organization, data collection and interpretation, and manuscript revisions. All authors read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>The Somanetics Corporation supplied transcranial oximetry computers and sensors. There are no conflicts of interest relating to the transcranial oximeter or the Somanetics Corporation. The Aspect Medical Systems, Inc. supplied the BIS computers. There are no conflicts of interest relating to the BIS monitor or the Aspect Medical Systems. No external funding was provided. Poster presentation at the 65th Annual Meeting of the American Association for the Surgery of Trauma, September 28 to 30, 2006, New Orleans, LA, USA.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaups</surname><given-names>KL</given-names></name><name><surname>Parks</surname><given-names>SN</given-names></name><name><surname>Morris</surname><given-names>CL</given-names></name></person-group><article-title>Intracranial pressure monitor placement by midlevel practitioners</article-title><source>J Trauma</source><year>1998</year><volume>45</volume><fpage>884</fpage><lpage>886</lpage><pub-id pub-id-type="pmid">9820697</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>K</given-names></name><name><surname>Conforti</surname><given-names>A</given-names></name></person-group><article-title>Training protocol for intracranial pressure monitor placement by nonneurosurgeons: 5-year experience</article-title><source>J Trauma</source><year>2003</year><volume>55</volume><fpage>480</fpage><lpage>483</lpage><pub-id pub-id-type="pmid">14501890</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><article-title>The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Intracranial pressure treatment threshold</article-title><source>J Neurotrauma</source><year>2000</year><volume>17</volume><fpage>493</fpage><lpage>495</lpage><pub-id pub-id-type="pmid">10937891</pub-id></citation></ref><ref id="B4"><citation citation-type="book"><source>Brain Trauma Foundation, Inc, American Association of Neurological Surgeons, Congress of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care Guidelines for the management of severe traumatic brain injury: cerebral perfusion pressure</source><year>2003</year><publisher-name>New York (NY): Brain Trauma Foundation, Inc.</publisher-name><fpage>1</fpage><lpage>14</lpage></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Globus</surname><given-names>MY</given-names></name><name><surname>Busto</surname><given-names>R</given-names></name><name><surname>Dietrich</surname><given-names>WD</given-names></name><name><surname>Martinez</surname><given-names>E</given-names></name><name><surname>Valdes</surname><given-names>I</given-names></name><name><surname>Ginsberg</surname><given-names>MD</given-names></name></person-group><article-title>Effect of ischemia on the <italic>in vivo </italic>release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis</article-title><source>J Neurochem</source><year>1988</year><volume>51</volume><fpage>1455</fpage><lpage>1464</lpage><pub-id pub-id-type="pmid">2902196</pub-id><pub-id pub-id-type="doi">10.1111/j.1471-4159.1988.tb01111.x</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Madsen</surname><given-names>PL</given-names></name><name><surname>Secher</surname><given-names>NH</given-names></name></person-group><article-title>Near-infrared oximetry of the brain</article-title><source>Prog Neurobiol</source><year>1999</year><volume>58</volume><fpage>541</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">10408656</pub-id><pub-id pub-id-type="doi">10.1016/S0301-0082(98)00093-8</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MB</given-names></name><name><surname>Ward</surname><given-names>DS</given-names></name><name><surname>Cartwright</surname><given-names>CR</given-names></name><name><surname>Kolano</surname><given-names>J</given-names></name><name><surname>Chlebowski</surname><given-names>S</given-names></name><name><surname>Henson</surname><given-names>LC</given-names></name></person-group><article-title>Estimation of jugular venous O2 saturation from cerebral oximetry or arterial O2 saturation during isocapnic hypoxia</article-title><source>J Clin Monit Comput</source><year>2000</year><volume>16</volume><fpage>191</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">12578103</pub-id><pub-id pub-id-type="doi">10.1023/A:1009940031063</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abdul-Khaliq</surname><given-names>H</given-names></name><name><surname>Troitzsch</surname><given-names>D</given-names></name><name><surname>Berger</surname><given-names>F</given-names></name><name><surname>Lange</surname><given-names>PE</given-names></name></person-group><article-title>Regional transcranial oximetry with near infrared spectroscopy (NIRS) in comparison with measuring oxygen saturation in the jugular bulb in infants and children for monitoring cerebral oxygenation</article-title><source>Biomed Tech (Berl)</source><year>2000</year><volume>45</volume><fpage>328</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">11155535</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dunham</surname><given-names>CM</given-names></name><name><surname>Ransom</surname><given-names>KJ</given-names></name><name><surname>Flowers</surname><given-names>LL</given-names></name><name><surname>Siegal</surname><given-names>JD</given-names></name><name><surname>Kohli</surname><given-names>CM</given-names></name></person-group><article-title>Cerebral hypoxia in severely brain-injured patients is associated with admission Glasgow Coma Scale score, computed tomographic severity, cerebral perfusion pressure, and survival</article-title><source>J Trauma</source><year>2004</year><volume>56</volume><fpage>482</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">15128117</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>S</given-names></name><name><surname>Grindlinger</surname><given-names>GA</given-names></name><name><surname>Desjardins</surname><given-names>S</given-names></name></person-group><article-title>Noninvasive cerebral oximetry in patients with traumatic brain injury</article-title><source>Crit Care Med</source><year>2004</year><volume>32</volume><issue>Suppl</issue><fpage>A104</fpage></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jordan</surname><given-names>KG</given-names></name></person-group><article-title>Continuous EEG monitoring in the neuroscience intensive care unit and emergency department</article-title><source>J Clin Neurophysiol</source><year>1999</year><volume>16</volume><fpage>14</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">10082089</pub-id><pub-id pub-id-type="doi">10.1097/00004691-199901000-00002</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosow</surname><given-names>C</given-names></name><name><surname>Manberg</surname><given-names>PJ</given-names></name></person-group><article-title>Bispectral index monitoring</article-title><source>Anesthesiol Clin North America</source><year>2001</year><volume>19</volume><issue>4</issue><fpage>947</fpage><lpage>966, xi</lpage><pub-id pub-id-type="pmid">11778388</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>CS</given-names></name><name><surname>Valadka</surname><given-names>AB</given-names></name><name><surname>Hannay</surname><given-names>HJ</given-names></name><name><surname>Contant</surname><given-names>CF</given-names></name><name><surname>Gopinath</surname><given-names>SP</given-names></name><name><surname>Cormio</surname><given-names>M</given-names></name><name><surname>Uzura</surname><given-names>M</given-names></name><name><surname>Grossman</surname><given-names>RG</given-names></name></person-group><article-title>Prevention of secondary ischemic insults after severe head injury</article-title><source>Crit Care Med</source><year>1999</year><volume>27</volume><fpage>2086</fpage><lpage>2095</lpage><pub-id pub-id-type="pmid">10548187</pub-id><pub-id pub-id-type="doi">10.1097/00003246-199910000-00002</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Juul</surname><given-names>N</given-names></name><name><surname>Morris</surname><given-names>GF</given-names></name><name><surname>Marshall</surname><given-names>SB</given-names></name><name><surname>Marshall</surname><given-names>LF</given-names></name></person-group><article-title>Intracranial hypertension and cerebral perfusion pressure: influence on neurological deterioration and outcome in severe head injury. The Executive Committee of the International Selfotel Trial</article-title><source>J Neurosurg</source><year>2000</year><volume>92</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10616075</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Howells</surname><given-names>T</given-names></name><name><surname>Elf</surname><given-names>K</given-names></name><name><surname>Jones</surname><given-names>PA</given-names></name><name><surname>Ronne-Engstrom</surname><given-names>E</given-names></name><name><surname>Piper</surname><given-names>I</given-names></name><name><surname>Nilsson</surname><given-names>P</given-names></name><name><surname>Andrews</surname><given-names>P</given-names></name><name><surname>Enblad</surname><given-names>P</given-names></name></person-group><article-title>Pressure reactivity as a guide in the treatment of cerebral perfusion pressure in patients with brain trauma</article-title><source>J Neurosurg</source><year>2005</year><volume>102</volume><fpage>311</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">15739560</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname><given-names>J</given-names></name></person-group><article-title>The first decade of continuous monitoring of jugular bulb oxyhemoglobin saturation: management strategies and clinical outcome</article-title><source>Crit Care Med</source><year>1998</year><volume>26</volume><fpage>344</fpage><lpage>351</lpage><pub-id pub-id-type="pmid">9468174</pub-id><pub-id pub-id-type="doi">10.1097/00003246-199802000-00039</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Isa</surname><given-names>R</given-names></name><name><surname>Wan Adnan</surname><given-names>WA</given-names></name><name><surname>Ghazali</surname><given-names>G</given-names></name><name><surname>Idris</surname><given-names>Z</given-names></name><name><surname>Ghani</surname><given-names>AR</given-names></name><name><surname>Sayuthi</surname><given-names>S</given-names></name><name><surname>Awang</surname><given-names>MS</given-names></name><name><surname>Ghazali</surname><given-names>MM</given-names></name><name><surname>Naing</surname><given-names>NN</given-names></name><name><surname>Abdullah</surname><given-names>JM</given-names></name></person-group><article-title>Outcome of severe traumatic brain injury: comparison of three monitoring approaches</article-title><source>Neurosurg Focus</source><year>2003</year><volume>15</volume><fpage>E1</fpage><pub-id pub-id-type="pmid">15305837</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fabregas</surname><given-names>N</given-names></name><name><surname>Gambus</surname><given-names>PL</given-names></name><name><surname>Valero</surname><given-names>R</given-names></name><name><surname>Carrero</surname><given-names>EJ</given-names></name><name><surname>Salvador</surname><given-names>L</given-names></name><name><surname>Zavala</surname><given-names>E</given-names></name><name><surname>Ferrer</surname><given-names>E</given-names></name></person-group><article-title>Can bispectral index monitoring predict recovery of consciousness in patients with severe brain injury?</article-title><source>Anesthesiology</source><year>2004</year><volume>101</volume><fpage>43</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">15220770</pub-id><pub-id pub-id-type="doi">10.1097/00000542-200407000-00009</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Riker</surname><given-names>RR</given-names></name><name><surname>Fraser</surname><given-names>GL</given-names></name><name><surname>Wilkins</surname><given-names>ML</given-names></name></person-group><article-title>Comparing the bispectral index and suppression ratio with burst suppression of the electroencephalogram during pentobarbital infusions in adult intensive care patients</article-title><source>Pharmacotherapy</source><year>2003</year><volume>23</volume><fpage>1087</fpage><lpage>1093</lpage><pub-id pub-id-type="pmid">14524640</pub-id><pub-id pub-id-type="doi">10.1592/phco.23.10.1087.32766</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vivien</surname><given-names>B</given-names></name><name><surname>Paqueron</surname><given-names>X</given-names></name><name><surname>Le Cosquer</surname><given-names>P</given-names></name><name><surname>Langeron</surname><given-names>O</given-names></name><name><surname>Coriat</surname><given-names>P</given-names></name><name><surname>Riou</surname><given-names>B</given-names></name></person-group><article-title>Detection of brain death onset using the bispectral index in severely comatose patients</article-title><source>Intensive Care Med</source><year>2002</year><volume>28</volume><fpage>419</fpage><lpage>425</lpage><pub-id pub-id-type="pmid">11967595</pub-id><pub-id pub-id-type="doi">10.1007/s00134-002-1219-4</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haug</surname><given-names>E</given-names></name><name><surname>Miner</surname><given-names>J</given-names></name><name><surname>Dannehy</surname><given-names>M</given-names></name><name><surname>Seigel</surname><given-names>T</given-names></name><name><surname>Biros</surname><given-names>M</given-names></name></person-group><article-title>Bispectral electroencephalographic analysis of head-injured patients in the emergency department</article-title><source>Acad Emerg Med</source><year>2004</year><volume>11</volume><fpage>349</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">15064207</pub-id><pub-id pub-id-type="doi">10.1197/j.aem.2003.12.015</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oertel</surname><given-names>M</given-names></name><name><surname>Kelly</surname><given-names>DF</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Glenn</surname><given-names>TC</given-names></name><name><surname>Vespa</surname><given-names>PM</given-names></name><name><surname>Martin</surname><given-names>NA</given-names></name></person-group><article-title>Is CPP therapy beneficial for all patients with high ICP?</article-title><source>Acta Neurochir Suppl</source><year>2002</year><volume>81</volume><fpage>67</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">12168358</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pillai</surname><given-names>S</given-names></name><name><surname>Praharaj</surname><given-names>SS</given-names></name><name><surname>Rao</surname><given-names>GS</given-names></name><name><surname>Kolluri</surname><given-names>VR</given-names></name></person-group><article-title>Cerebral perfusion pressure management of severe diffuse head injury: effect on brain compliance and intracranial pressure</article-title><source>Neurol India</source><year>2004</year><volume>52</volume><fpage>67</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">15069242</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Injury characteristics of 18 consecutive patients with severe traumatic brain injury</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center">Mean/number</td><td align="center">SD/percent</td></tr></thead><tbody><tr><td align="left">Age</td><td align="center">34.3</td><td align="center">13.1</td></tr><tr><td align="left">Male</td><td align="center">11</td><td align="center">61.1 percent</td></tr><tr><td align="left">Female</td><td align="center">7</td><td align="center">38.9 percent</td></tr><tr><td align="left">Weight (kg)</td><td align="center">80.3</td><td align="center">15.7</td></tr><tr><td align="left">Height (cm)</td><td align="center">175.4</td><td align="center">8.1</td></tr><tr><td align="left">ISS</td><td align="center">37.2</td><td align="center">8.9</td></tr><tr><td align="left">Admission GCS</td><td align="center">4.4</td><td align="center">1.9</td></tr><tr><td align="left">Brain AIS score</td><td align="center">4.9</td><td align="center">0.2</td></tr><tr><td align="left">Admission lactate</td><td align="center">4.5</td><td align="center">2.7</td></tr><tr><td align="left">Admission base deficit</td><td align="center">-6.8</td><td align="center">5.1</td></tr><tr><td align="left">Admission glucose</td><td align="center">203.7</td><td align="center">80.3</td></tr><tr><td align="left">RBC units</td><td align="center">1.4</td><td align="center">3.3</td></tr><tr><td align="left">Admission WBC count</td><td align="center">19.6</td><td align="center">7.5</td></tr><tr><td align="left">Craniotomy</td><td align="center">8</td><td align="center">44.4 percent</td></tr><tr><td align="left">Bone flap removal</td><td align="center">6</td><td align="center">33.3 percent</td></tr><tr><td align="left">EDH</td><td align="center">2</td><td align="center">11.1 percent</td></tr><tr><td align="left">SDH</td><td align="center">7</td><td align="center">38.9 percent</td></tr><tr><td align="left">Cerebral hemorrhage</td><td align="center">11</td><td align="center">61.1 percent</td></tr><tr><td align="left">Cerebral edema</td><td align="center">3</td><td align="center">16.7 percent</td></tr><tr><td align="left">Midline shift</td><td align="center">8</td><td align="center">44.4 percent</td></tr><tr><td align="left">Abnormal cisterns</td><td align="center">10</td><td align="center">55.6 percent</td></tr><tr><td align="left">SAH</td><td align="center">12</td><td align="center">66.7 percent</td></tr><tr><td align="left">Discharge GCS</td><td align="center">9.7</td><td align="center">3.7</td></tr><tr><td align="left">Lived</td><td align="center">16</td><td align="center">88.9 percent</td></tr><tr><td align="left">Died</td><td align="center">2</td><td align="center">11.1 percent</td></tr><tr><td align="left">Good neurological outcome</td><td align="center">14</td><td align="center">77.8 percent</td></tr><tr><td align="left">Poor neurological outcome</td><td align="center">4</td><td align="center">22.2 percent</td></tr></tbody></table><table-wrap-foot><p>AIS, Abbreviated Injury Scale; EDH, epidural hematoma; GCS, Glasgow Coma Scale; ISS, Injury Severity score; RBC, red blood cell; SAH, subarachnoid hemorrhage; SD, standard deviation; SDH, subdural hematoma; WBC, white blood cell.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Surviving and good neurological outcome patients have increased CPP, StcO<sub>2</sub>, and BIS and decreased ICP and CAP Index</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center">Hours</td><td align="center">ICP</td><td align="center">CPP</td><td align="center">CAP Index</td><td align="center">StcO<sub>2</sub></td><td align="center">BIS</td></tr></thead><tbody><tr><td align="left">Live</td><td align="center">1,683</td><td align="center">11.8 &#x000b1; 6.1</td><td align="center">81.5 &#x000b1; 13.5</td><td align="center">0.15 &#x000b1; 0.10</td><td align="center">70.0 &#x000b1; 9.3</td><td align="center">51.1 &#x000b1; 16.5</td></tr><tr><td align="left">Die</td><td align="center">200</td><td align="center">30.0 &#x000b1; 11.1</td><td align="center">66.6 &#x000b1; 21.6</td><td align="center">0.63 &#x000b1; 0.79</td><td align="center">61.0 &#x000b1; 5.2</td><td align="center">47.8 &#x000b1; 12.9</td></tr><tr><td align="left"><italic>p </italic>value</td><td></td><td align="center">&#x0003c;0.0001</td><td align="center">&#x0003c;0.0001</td><td align="center">&#x0003c;0.0001</td><td align="center">&#x0003c;0.0001</td><td align="center">0.002</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">Good outcome</td><td align="center">1,479</td><td align="center">11.8 &#x000b1; 6.4</td><td align="center">82.1 &#x000b1; 13.8</td><td align="center">0.15 &#x000b1; .10</td><td align="center">71.2 &#x000b1; 9.1</td><td align="center">52.9 &#x000b1; 16.8</td></tr><tr><td align="left">Poor outcome</td><td align="center">404</td><td align="center">20.8 &#x000b1; 12.3</td><td align="center">72.0 &#x000b1; 17.7</td><td align="center">0.39 &#x000b1; .61</td><td align="center">61.2 &#x000b1; 5.4</td><td align="center">44.4 &#x000b1; 13.0</td></tr><tr><td align="left"><italic>p </italic>value</td><td></td><td align="center">&#x0003c;0.0001</td><td align="center">&#x0003c;0.0001</td><td align="center">&#x0003c;0.0001</td><td align="center">&#x0003c;0.0001</td><td align="center">&#x0003c;0.0001</td></tr></tbody></table><table-wrap-foot><p>BIS, Bispectral Index; CAP Index, Cranial-Arterial Pressure Index (ICP/(MAP - ICP)); CPP, cerebral perfusion pressure; ICP, intracranial pressure; MAP, mean arterial pressure; StcO<sub>2</sub>, transcranial oxygen saturation.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>StcO<sub>2 </sub>and BIS have an inverse association with ICP and CAP Index and a direct association with CPP</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center" colspan="5">StcO<sub>2</sub></td><td align="center" colspan="5">BIS</td></tr></thead><tbody><tr><td></td><td align="center">&#x02265;70 (percent)</td><td align="center">&#x0003c;70 (percent)</td><td align="center">OR</td><td align="center">95 percent CI</td><td align="center"><italic>p </italic>value</td><td align="center">&#x02265;60 (percent)</td><td align="center">&#x0003c;60 (percent)</td><td align="center">OR</td><td align="center">95 percent CI</td><td align="center"><italic>p </italic>value</td></tr><tr><td colspan="11"><hr></hr></td></tr><tr><td align="left">ICP &#x0003e;20</td><td align="center">9.8</td><td align="center">20.6</td><td align="center">0.42</td><td align="center">0.32&#x02013;0.55</td><td align="center">&#x0003c;0.0001</td><td align="center">6.5</td><td align="center">19.0</td><td align="center">0.30</td><td align="center">0.21&#x02013;0.43</td><td align="center">&#x0003c;0.0001</td></tr><tr><td align="left">CAP Index &#x0003e;0.30</td><td align="center">7.9</td><td align="center">17.7</td><td align="center">0.40</td><td align="center">0.30&#x02013;0.54</td><td align="center">&#x0003c;0.0001</td><td align="center">5.3</td><td align="center">16.1</td><td align="center">0.29</td><td align="center">0.19&#x02013;0.44</td><td align="center">&#x0003c;0.0001</td></tr><tr><td align="left">CPP &#x02265; 60</td><td align="center">97.5</td><td align="center">90.3</td><td align="center">4.2</td><td align="center">2.6&#x02013;6.8</td><td align="center">&#x0003c;0.0001</td><td align="center">97.8</td><td align="center">92.2</td><td align="center">3.7</td><td align="center">2.0&#x02013;7.0</td><td align="center">&#x0003c;0.0001</td></tr></tbody></table><table-wrap-foot><p>BIS, bispectral index; CAP Index, Cranial-Arterial Pressure Index (ICP/(MAP - ICP)); CI, confidence intervals; CPP, cerebral perfusion pressure; ICP, intracranial pressure; OR, odds ratio; StcO<sub>2</sub>, transcranial oxygen saturation.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>StcO<sub>2 </sub>and BIS have a direct association</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center">BIS &#x02265; 60 (percent)</td><td align="center">BIS &#x0003c;60 (percent)</td><td align="center">OR</td><td align="center">95 percent CI</td><td align="center"><italic>p </italic>value</td></tr></thead><tbody><tr><td align="left">StcO<sub>2 </sub>&#x02265; 70</td><td align="center">39.9</td><td align="center">60.1</td><td align="center">2.4</td><td align="center">2.0&#x02013;3.0</td><td align="center">&#x0003c;0.0001</td></tr><tr><td align="left">StcO<sub>2 </sub>&#x0003c;70</td><td align="center">21.7</td><td align="center">78.3</td><td></td><td></td><td></td></tr></tbody></table><table-wrap-foot><p>BIS, bispectral index; CI, confidence intervals; OR, odds ratio; StcO<sub>2</sub>, transcranial oxygen saturation.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>BIS &#x02265; 60 or StcO<sub>2 </sub>&#x02265; 70 are associated with survival, good neurological outcome, CPP, ICP, CAP Index, and ICP interventions</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center">BIS &#x02265; 60/StcO<sub>2 </sub>&#x02265; 70 (percent)</td><td align="center">BIS &#x0003c;60/StcO<sub>2 </sub>&#x0003c;70 (percent)</td><td align="center">OR</td><td align="center">95 percent CI</td><td align="center"><italic>p </italic>value</td></tr></thead><tbody><tr><td align="left">Live</td><td align="center">67.7</td><td align="center">32.3</td><td align="center">30.1</td><td align="center">16.6&#x02013;55.8</td><td align="center">&#x0003c;0.0001</td></tr><tr><td align="left">Die</td><td align="center">6.5</td><td align="center">93.5</td><td></td><td></td><td></td></tr><tr><td align="left">Good neurological outcome</td><td align="center">74.8</td><td align="center">25.2</td><td align="center">23.1</td><td align="center">16.4&#x02013;32.5</td><td align="center">&#x0003c;0.0001</td></tr><tr><td align="left">Poor neurological outcome</td><td align="center">11.4</td><td align="center">88.6</td><td></td><td></td><td></td></tr><tr><td align="left">CPP &#x02265; 60</td><td align="center">97.2</td><td align="center">88.7</td><td align="center">4.5</td><td align="center">2.9&#x02013;7.0</td><td align="center">&#x0003c;0.0001</td></tr><tr><td align="left">CPP &#x0003c;60</td><td align="center">2.8</td><td align="center">11.4</td><td></td><td></td><td></td></tr><tr><td align="left">ICP &#x02264; 20</td><td align="center">90.8</td><td align="center">75.5</td><td align="center">3.2</td><td align="center">2.4&#x02013;4.2</td><td align="center">&#x0003c;0.0001</td></tr><tr><td align="left">ICP &#x0003e;20</td><td align="center">9.2</td><td align="center">24.5</td><td></td><td></td><td></td></tr><tr><td align="left">CAP Index &#x02264; 0.30</td><td align="center">92.4</td><td align="center">79.1</td><td align="center">3.2</td><td align="center">2.4&#x02013;4.3</td><td align="center">&#x0003c;0.0001</td></tr><tr><td align="left">CAP Index &#x0003e;0.30</td><td align="center">7.6</td><td align="center">20.9</td><td></td><td></td><td></td></tr><tr><td align="left">No mannitol/CSF drainage</td><td align="center">85.7</td><td align="center">62.4</td><td align="center">3.6</td><td align="center">2.9&#x02013;4.5</td><td align="center">&#x0003c;0.0001</td></tr><tr><td align="left">Mannitol/CSF drainage</td><td align="center">14.3</td><td align="center">37.6</td><td></td><td></td><td></td></tr></tbody></table><table-wrap-foot><p>BIS, Bispectral Index; CAP Index, Cranial-Arterial Pressure Index (ICP/(MAP - ICP)); CI, confidence intervals; CPP, cerebral perfusion pressure; CSF, cerebrospinal fluid; ICP, intracranial pressure; OR, odds ratio; StcO<sub>2</sub>, transcranial oxygen saturation.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T6"><label>Table 6</label><caption><p>An increasing CAP Index indicates a modest reduction in MAP and substantial increase in ICP</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">CAP Index range</td><td align="center">Number</td><td align="center">Percent</td><td align="center">MAP</td><td align="center">ICP</td><td align="center">CPP</td><td align="center">CAP Index</td></tr></thead><tbody><tr><td align="left">0.01&#x02013;0.10</td><td align="center">521</td><td align="center">27.7</td><td align="center">95.7</td><td align="center">5.2</td><td align="center">90.4</td><td align="center">0.06</td></tr><tr><td align="left">0.11&#x02013;0.20</td><td align="center">745</td><td align="center">39.6</td><td align="center">93.3</td><td align="center">12.1</td><td align="center">81.3</td><td align="center">0.15</td></tr><tr><td align="left">0.21&#x02013;0.30</td><td align="center">377</td><td align="center">20.0</td><td align="center">93.7</td><td align="center">18.1</td><td align="center">75.6</td><td align="center">0.24</td></tr><tr><td align="left">0.31&#x02013;0.40</td><td align="center">106</td><td align="center">5.6</td><td align="center">91.2</td><td align="center">23.2</td><td align="center">68.0</td><td align="center">0.34</td></tr><tr><td align="left">&#x0003e; 0.40</td><td align="center">134</td><td align="center">7.1</td><td align="center">89.4</td><td align="center">36.8</td><td align="center">52.5</td><td align="center">0.87</td></tr></tbody></table><table-wrap-foot><p>CAP Index, Cranial-Arterial Pressure Index (ICP/(MAP - ICP)); CPP, cerebral perfusion pressure; ICP, intracranial pressure; MAP, mean arterial pressure.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T7"><label>Table 7</label><caption><p>The CAP Index is increased with death, poor neurological outcome, and need for interventions to lower ICP</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center">CAP Index</td><td align="center"><italic>p </italic>value</td></tr></thead><tbody><tr><td align="left">Die</td><td align="center">0.63</td><td align="center">&#x0003c;0.0001</td></tr><tr><td align="left">Live</td><td align="center">0.15</td><td></td></tr><tr><td align="left">Poor neurological outcome</td><td align="center">0.39</td><td align="center">&#x0003c;0.0001</td></tr><tr><td align="left">Good neurological outcome</td><td align="center">0.15</td><td></td></tr><tr><td align="left">Mannitol/CSF drainage</td><td align="center">0.27</td><td align="center">&#x0003c;0.0001</td></tr><tr><td align="left">No mannitol/CSF drainage</td><td align="center">0.18</td><td></td></tr></tbody></table><table-wrap-foot><p>CAP Index, Cranial-Arterial Pressure Index (ICP/(MAP - ICP)); CSF, cerebrospinal fluid; ICP, intracranial pressure.</p></table-wrap-foot></table-wrap></sec></back></article>


